|
May
6,
2003 Issue 154
This
Week...
 Do
you have an Abstract or Study?? We want to share diabetes
practice
information across different disciplines. If
you have prepared an abstract or poster that deals with
patient care, please send it to me at editor@diabetesincontrol.com
Our
first abstract is from Dr. Nicole M. Paolini,
Pharm.D., Clinical Assistant Professor, Department of
Pharmacy Practice,
University of Buffalo and addresses the issue of
Community Practice Patients Meeting ADA Goals.
Dr
Timothy S. Hollingshead, joins us to share the secrets
of his program “Going Beyond The Successful Practice”.
His program helps you create more free time, generate improved
profits, and eliminate stress and frustration, while returning
you to the joy of practicing. He begins with
PATIENT CARE OR CUSTOMER SERVICE?
Last
week we mentioned a new case study from the Denver
Health Medical Center showing the Benefits of Anodyne Therapy.
Due to a technical problem we did not have it linked. Please
click here to review the case study. CASE STUDY
We
are upgrading our Tools for Your Practice page. Starting
next week you will be able to view and print any and all
tools quickly and easily.
Check out this weeks Tools for Your Practice: GlucoControl:
Free PDA Software
This
week’s overview:
Item#1: Long Term Enalapril Therapy Slows Damage
Item:#12: Calcium Channel Blocker Vs. Beta Blocker in Reducing
Risks
Item
#15: Culture: It’s Effect on Your Abilities to
Educate
Check
out this weeks “Test Your Knowledge” question.
Click Here
Dave
Joffe, Editor-in-Chief
Consider making Diabetes
in Control Your home page.
News Flash - News Flash!!!!!
Obese
and overweight women face significantly
increased risks of having babies with heart abnormalities and
other birth defects, according to a government study.
The study was released today in May’s editions of the
journal Pediatrics. See Item #8
FDA Approves LANTUS(insulin glargine [rDNA origin]) for
a more flexible dosing regimen, from once daily at bedtime
to flexible daily dosing.
1.
Long-Term Enalapril Slows Disease Damage In Diabetics*
Click Here
2. New Inhaled Insulin Study
Click Here
3. Glitazone Not Contraindicated in Diabetics With Heart Failure
Click Here
4. New Anti-Inflammatory Drug May Help Prevent Diabetes*
Click Here
5. Sesame Oil Improves Antihypertensive Effect of Nifedipine
Click Here
6. Physical Activity Can Reduce CVD Risk & Mortality in Diabetic Men
Click Here
7. Major Shortage of Endocrinologists in the United States*
Click Here
8. Risk of Birth Defects Greater for Overweight Mothers
Click Here
9. Advanced Heart Failure Associated With Development of Diabetes
Click Here
10. Vigorous Exercise Vs. Walking to Prevent Heart Attacks
Click Here
11. Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic
Visits
Click Here
12. Calcium Channel Blocker Rivals Beta Blocker in Preventing Death, Stroke and
Diabetes*
Click Here
13. Metformin's Diabetes Preventive Effects Persist After Drug Withdrawal
Click Here
14. Fluid Retention Reversible In Diabetics Treated With TZD’s
Click Here
15. The Role of Culture in Patient Care
Click
Here
Product Update
A1cNow
is Now Over the Counter-No Prescription Needed!
Let
your Patients Check Their Own A1c Levels. It will motivate
to better control.
www.a1cnow.net
Packed
with Many Valuable Features...
you'd expect to pay
over $2000.00 for a Website Like This...
See
Examples, and Learn More.....>
Click Here
QUOTE OF THE WEEK
"A
physician will never dispute any new method of treatment
without first trying
it"
--------------Hippocrates
Importing
Drugs from Canada is Growing But!…….Beware!
 Over
$600 million in Rx imports in just the last year. It’s
mostly through the mail...from Internet pharmacies.
The lower prices are due to Canadian gov't price
controls and favorable Canadian currency conversion
rates.
Most
Canadian provinces don't allow pharmacists to fill
Rxs from U.S. physicians...so Canadian physicians "rewrite" them.
U.S. law says importation is illegal...but most
patients have no idea they're breaking the law. Read More |
Fiber
2
We
have openings for a couple of more medical professionals
to participate in the Fiber 2 Study.
“
The Clinical Impact of Fiber Supplementation for the
Reduction of Postprandial Blood Glucose and Risk Reduction
of Complications from Diabetes in Type 2 Diabetes” For
more information and to sign up: Fiber 2 Study
Click
Here
|
Free
CME
The
Hyperactive Platelet in Type 2 Diabetes-
Sponsored
by Baylor College of Medicine, Houston, Texas,
offers 2 hours of AMA PRA category 1 credit To
access this free on-line activity, visit Click
Here |
|
Joins
us to share the secrets of his program “Going Beyond The Successful
Practice”. 
The
Hypoguard Advance- The first
disposable glucose meter. The
Advance contains 100 test strips
and comes ready to use- no calibration.
Called the Hypoguard Advance,
the meter recently received 510K
approval from the FDA and plans
are underway to have the meter
in stores sometime later this
year. With an expected retail
cost of around $70 or $75, about
the same price as a box of 100
premium test strips.
Visit
Sherri
Shafer's
Archives 
Long-Term
Enalapril Slows Disease Damage In Diabetics*
Evan
D. Rosen, M.D., Ph.D 
Check
out Dr.
Bernsteins
Corner for
Insights for
Controlling
Blood Sugars
Why
Focusing On Intensive Glucose